Skip to main content
Premium Trial:

Request an Annual Quote

Celera AgGen in Bovine Gene Deal with ViaLactia

Premium

ROCKVILLE, Md.--Celera Genomics' AgGen business, in a deal with New Zealand company ViaLactia Biosciences, will search for genes important for dairy productivity in the bovine genome. The deal calls for Celera to use its high-throughput DNA sequencing, library development, and advanced bioinformatics capabilities to identify important expressed genes in dairy cattle. ViaLactia, which has access to cattle populations, related phenotypic information, and knowledge of the dairy industry, plans to use the gene data for integrated breeding programs in New Zealand. Intellectual property resulting from the project will be jointly owned.

Filed under

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.